Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Current Leases (2020 - 2025)

Dare Bioscience's Current Leases history spans 6 years, with the latest figure at $602552.0 for Q4 2025.

  • For Q4 2025, Current Leases changed N/A year-over-year to $602552.0; the TTM value through Dec 2025 reached $602552.0, changed N/A, while the annual FY2025 figure was $602552.0, N/A changed from the prior year.
  • Current Leases reached $602552.0 in Q4 2025 per DARE's latest filing, down from $1.9 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.9 million in Q3 2025 to a low of $195000.0 in Q3 2023.
  • Average Current Leases over 5 years is $487977.8, with a median of $419000.0 recorded in 2021.
  • Peak YoY movement for Current Leases: plummeted 49.74% in 2023, then surged 269.61% in 2025.
  • A 5-year view of Current Leases shows it stood at $270546.0 in 2021, then surged by 47.25% to $398391.0 in 2022, then rose by 17.65% to $468726.0 in 2023, then grew by 7.91% to $505824.0 in 2024, then grew by 19.12% to $602552.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Current Leases are $602552.0 (Q4 2025), $1.9 million (Q3 2025), and $588478.0 (Q2 2025).